Frank Lis
Chief Executive Officer at Kineticos Ventures LLC
Profile
Frank Lis is currently the President and CEO at Kineticos Ventures LLC, an Advisor at Inceptor Bio LLC, and a Board Member at Diant Pharma, Inc. In the past, he worked as the Director of Business Development at Omnicare LLC from 1998 to 2000, as the VP of Sales Pharmaceutical Development at Cardinal Health, Inc. from 2002 to 2007, and as the Vice President at Catalent, Inc. from 2007 to 2014.
Mr. Lis received his undergraduate degree from Villanova University.
Frank Lis active positions
| Companies | Position | Start |
|---|---|---|
Kineticos Ventures LLC
 Kineticos Ventures LLC Investment ManagersFinance Kineticos Ventures LLC (Kineticos Ventures) is a private equity subsidiary of Kineticos Life Sciences LLC founded in 2019. The firm is headquartered in Raleigh, North Carolina. | Chief Executive Officer | 2021-03-31 |
Diant Pharma, Inc.
 Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Director/Board Member | 2022-09-30 |
Inceptor Bio LLC
 Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Consultant / Advisor | 2021-05-31 |
Former positions of Frank Lis
| Companies | Position | End |
|---|---|---|
| CATALENT, INC. | Private Equity Investor | 2014-08-29 |
| CARDINAL HEALTH, INC. | Private Equity Investor | 2007-04-29 |
| OMNICARE, INC. | Private Equity Investor | 2000-09-29 |
Training of Frank Lis
| Villanova University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| CATALENT, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Omnicare LLC
 Omnicare LLC Drugstore ChainsRetail Trade Omnicare LLC provides pharmaceutical services to patients and providers. It serves long term and post acute facility services and senior living. The company was founded on May 19, 1981 and is headquartered in Cincinnati, OH. | Retail Trade |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Health Technology |
Kineticos Ventures LLC
Kineticos Ventures LLC Investment ManagersFinance Kineticos Ventures LLC (Kineticos Ventures) is a private equity subsidiary of Kineticos Life Sciences LLC founded in 2019. The firm is headquartered in Raleigh, North Carolina. | Finance |
Diant Pharma, Inc.
Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Health Technology |
- Stock Market
- Insiders
- Frank Lis